Afshar-Kharghan V. The role of the complement system in cancer. J Clin Invest. 2017;127:780-9.
Cao W, Wei W, Zhan Z, Xie Y, Xiao Q. MiR-1284 modulates multidrug resistance of gastric cancer cells by targeting EIF4A1. Oncol Rep. 2016;l35:2583–2591
Day KC, Lorenzatti Hiles G, Kozminsky M, Dawsey SJ, Paul A, Broses LJ, Shah R, Kunja LP, Hall C, Palanisamy N, Daignault-Newton S, El-Sawy L, Wilson SJ, Chou A, Ignatoski KW, Keller E, Thomas D, Nagrath S, Morgan T, Day ML. HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone. Cancer research. 2017;77:74-85
Gasparetto M, Smith CA. ALDHs in normal and malignant hematopoietic cells: Potential new avenues for treatment of AML and other blood cancers. Chemico-Biological Interactions. 2017;276:46-51.
Hirte H, Kennedy EB, Elit L, Fung Kee Fung M. Systemic therapy for recurrent, persistent, or metastatic cervical cancer: a clinical practice guideline. Curr Oncol. 2015;22:211–219.
Huang M, Wu L, Luo S, Qin H, Yang Y, Chen J, Li Z, Qin Y. MicroRNA-1284 inhibits proliferation and induces apoptosis in SGC-7901 human gastric cancer cells. Biotechnol. Lett. 2017;39:33–38.
Ichihara H, Motomura M, Matsumoto Y. Therapeutic effects and anti-metastasis effects of cationic liposomes against pancreatic cancermetastasis in vitro and in vivo. Biochem Biophys Res Commun. doi: 10.1016/j.bbrc.2019.02.116.
Jin T, Wu X, Yang H, Liu H, He Y, He X, Shi X, Wang F, Du S, Ma Y, Bao S, Yuan D. Association of the miR-17-5p variants with susceptibility to cervical cancer in a Chinese population. Oncotarget 2016;7:76647–76655.
Kanavos PP. The rising burden of cancer in the developing world. Ann Oncol. 2006;17:viii15–viii23.
Lockhart JN, Stevens DM, Beezer DB, Kravitz A, Harth E. Dual drug delivery of tamoxifen and quercetin: regulated metabolism for anticancer treatment with nanosponges. J Control Release 2015;220:751–757.
Li J, Jin H, Yu H, Wang B, Tang J. miRNA1284 inhibits cell growth and induces apoptosis of lung cancer cells. Mol Med Rep. 2017;16:3049–3054.
Li B, Gao MH, Chu XM, Xu YJ, Yang F. Identification of a novel short peptide seal specific to CD59 and its effect on HeLa cell growth and apoptosis. Cellular Oncology. 2012;35:355-65
Oberoi HS, Nukolova NV, Kabanov AV, Bronich TK. Nanocarriers for delivery of platinum anticancer drugs. Adv Drug Deliv Rev. 2013;65:1667–1685.
Pan C, Wang D, Zhang Y, Yu W. MicroRNA-1284 inhibits cell viability and induces apoptosis of ovarian Cancer cell line OVCAR3. Oncol Res. 2016;24:429–435.
Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003;55:329–347
Ramasamy T, Ruttala HB, Kaliraj K, Poudel K, Jin SG, Choi HG, Ku SK, Yong CS, Kim JO. Polypeptide derivative of metformin with the combined advantage of a gene carrier and anticancer activity. ACS Biomater Sci Eng. 2019;10:5159-5168
Ramasamy T, Ruttala HB, Gupta B, Poudel BK, Choi HG, Yong CS, Kim JO. Smart chemistry-based nanosized drug delivery systems for systemic applications: A comprehensive review.J Control Release. 2017;258:226-253.
Shin VY, Chu KM. MiRNA as potential biomarkers and therapeutic targets for gastric cancer. World J Gastroenterol. 2014;20:10432–10439.
Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29
Scatchard K, Forrest JL, Flubacher M, Cornes P, Williams C. Chemotherapy for metastatic and recurrent cervical cancer. Cochrane Database Syst Rev. 2012;10:CD006469.
Wang Z, Lv J, Zhang T. Combination of IL-24 and cisplatin inhibits angiogenesis and lymphangiogenesis of cervical cancer xenografts in a nude mouse model by inhibiting VEGF, VEGF-C and PDGF-B. Oncol Rep. 2015;33:2468–2476.
Wu L, Yang L. The function and mechanism of HMGB1 in lung cancer and its potential therapeutic implications, Oncol Lett. 2018;15:6799–6805.
Zhang X, Dai F, Chen J, Xie X, Xu H, Bai C, Qiao W, Shen W. Antitumor effect of curcumin liposome after transcatheter arterial embolization in VX2 rabbits. Cancer Biol Ther. 2019. doi: 10.1080/15384047.2018.1550567